Article Details
Retrieved on: 2022-12-24 00:10:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech and its partner for China, Shanghai Fosun Pharmaceutical , were granted approval for their COVID-19 vaccine that is adapted for the BA.4 ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here